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ABSTRACT 
Wnt signaling pathways are of significant 
interest in development and oncogenesis. The 
first step in these pathways typically involves 
the binding of a Wnt protein to the cysteine-
rich domain (CRD) of a Frizzled receptor; 
Wnt-Frizzled interactions can be antagonized 
by secreted Frizzled-related proteins (sFRPs), 
which also contain a Frizzled-like CRD. The 
large number of Wnts, Frizzleds and sFRPs, as 
well as the hydrophobic nature of Wnt, pose 
challenges to laboratory-based investigations 
of interactions involving Wnt. Here, utilizing 
structural knowledge of a representative Wnt-
Frizzled CRD interaction, as well as 
experimentally-determined binding affinities 
for a selection of Wnt-Frizzled CRD 
interactions, we generate homology models of 
Wnt-Frizzled CRD interactions and develop a 
quantitative structure-activity relationship for 
predicting their binding affinities. The derived 
model incorporates a small selection of terms 
derived from scoring functions used in 
protein-protein docking, as well as an 
energetic term considering the contribution 
made by the lipid of Wnt to the Wnt-Frizzled 
binding affinity. Validation with an external 
test set suggests that the model can accurately 
predict binding affinity for 75% of cases, and 
that the error associated with the predictions 
is comparable to the experimental error. The 
model was applied to predict the binding 
affinities of the full range of mouse and human 
Wnt-Frizzled and Wnt-sFRP interactions, 
indicating trends in Wnt binding affinity for 
Frizzled and sFRP CRDs. The comprehensive 
predictions made in this study provide the 
basis for laboratory-based studies of 
previously unexplored Wnt-Frizzled and Wnt-
sFRP interactions, which in turn, may reveal 
further Wnt signaling pathways. 
 
 
The Wnt signaling pathway is an evolutionary 
conserved pathway found in vertebrates and 
insects (1). It functions to regulate body axis 
formation, cell fate, cell proliferation and 
morphogenesis in embryonic development (2), 
while aberrant Wnt signaling is a hallmark of 
many cancers (3). Wnt signaling pathways can be 
divided into three separate branches, a canonical, 
or -catenin dependent pathway, and two non-
canonical or -catenin independent pathways, 
known as the planar cell polarity (PCP) and 
Wnt/Ca2+ pathways (4,5) (Figure 1). Wnt 
signaling is generally initiated by the binding of 
Wnt ligands binding to a Frizzled (Fzd) receptor 
(6). In the canonical Wnt signaling pathway 
(Figure 1a), low-density-lipoprotein-related 
protein 5/6 (LRP5/6) acts as a co-receptor for Wnt 
binding (7). Signal transduction by the three 
major Wnt signaling pathways is regulated by the 
interaction of Fzd with the cytoplasmic protein 
Dishevelled (Dvl) (8). In the canonical pathway, 
-catenin dependent signaling is mediated 
through the cytoplasmic ‘destruction complex’ 
composed of Axin, protein phosphatase 2A 
(PP2A), adenomatous polyposis coli protein 
(APC), glycogen synthase kinase 3 (GSK3) and 
casein kinase 1 (CK1) (9). In the presence of 
Wnt stimulation, Fzd is activated, permitting Dvl 
binding, and resulting in the stabilization of the 
destruction complex and the accumulation of 
non-phosphorylated -catenin, which then 
translocates to the nucleus and binds to TCF/LEF 
transcription factors on the promoter of target 
genes (4). In the absence of Wnt stimulation, the 
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destruction complex is destabilized, allowing for 
the phosphorylation of -catenin by CK1 and 
GSK3 (10); phosphorylated β-catenin is then 
proteolytically degraded (11). The Wnt/Ca2+ 
pathway (Figure 1b) is activated through Wnt 
ligands binding to Fzd receptors, resulting in an 
increase in intracellular calcium (12). Calcium 
ions are able to activate both calmodulin-
dependent protein kinase II (CaMKII) (13) and 
protein kinase C (PKC) (14), which subsequently 
activate transcription factors NFB and CREB. 
The cytosolic phosphatase, calcinurin (Cn), is 
also activated by calcium ions. Cn-dependent 
dephosphorylation, and activation of NFAT, 
leads to the transcription of genes in 
cardiomyocytes, neuronal cells and skeletal 
muscle (15). Signal transduction via the PCP 
pathway (Figure 1c) is initiated through Wnt 
binding to Fzd and co-receptors receptor tyrosine 
kinase-like receptor ROR and Ryk. Fzd activation 
leads to Dvl-mediated activation of Rac and Rho. 
JNK and Rho kinase (ROCK) are activated by 
Rac and Rho, respectively which mediates actin 
polymerization and activates transcription factors 
AP-1 and JUN (16). 
Wnts comprise a group of 19 proteins that 
are subject to numerous post-translational 
modifications, including the formation of a large 
number of characteristic disulfide bonds, 
glycosylation in the endoplasmic reticulum (17), 
and palmitoleylation by Porcupine, which aids in 
their secretion and facilitates their interaction 
with Frizzled (18). Structurally, as determined by 
the co-crystallization of Xenopus Wnt8 (XWnt8) 
with the mouse Fzd8 CRD, Wnts are composed 
of two domains: an amino-terminal (NTD) and 
carboxy-terminal domain (CTD) (19). The NTD 
contains 10 cysteine residues forming 5 disulfide 
bridges, in a cluster of -helices, while the CTD 
contains 6 disulfide bridges and a two-stranded -
sheet (19). Frizzled receptors are a group of ten 
membrane-bound receptors comprising the 
majority of Class F G-coupled protein receptors 
(GPCRs). Frizzleds, like other GPCRs, consist of 
seven hydrophobic transmembrane helices, but 
feature an extracellular cysteine-rich domain 
(CRD) in their N-terminal (20). The CRD is 
characterized by a conserved pattern of ten 
cysteines, and can bind Wnt and Norrin ligands 
(21,22). The five mammalian secreted frizzled 
related proteins (sFRPs) are secreted 
glycoproteins, composed of an N-terminal CRD 
located and a C-terminal netrin-like domain 
(NLD) (23). These proteins function to 
antagonize the Wnt signaling pathway (24) 
through binding of either the CRD (25) or the 
NLD to Wnt ligands (26), thus interfering with 
Wnt binding to Fzd and preventing β-catenin-
mediated gene transcription. The sFRPs have 
been studied in great detail for their potential 
roles as tumor suppressors and their implications 
in carcinogenesis (23). 
Due to the large number of possible Wnt-
Fzd CRD interactions (which, considering CRDs 
from both Fzds and sFRPs, totals 285 interactions 
per species), it is challenging to investigate these 
experimentally. A recent study utilized biolayer 
interferometry (BLI) to investigate a small set of 
mouse Wnt-Fzd CRD interactions in a 
combinatorial manner (27). Numerous other 
interactions have been identified via co-
immunoprecipitation (coIP), or proposed based 
on co-expression of particular Wnts with 
particular Fzds (6). While coIP and co-expression 
are valuable methods for suggesting the existence 
of specific protein-protein interactions, they are 
unable to provide an indication of the likely 
strength of an interaction. Computational studies 
provide the opportunity to complete the 
knowledge of interactions between Wnts and Fzd 
CRDs, and may reveal previously unexplored 
high affinity interactions. 
 In this study, we have generated 
homology models of Wnt complexes with both 
Fzd and sFRP CRDs and predict the likely 
binding affinity associated with these 
interactions. For a series of Wnt-Fzd CRD 
interactions for which dissociation constants have 
been reported (27), we then evaluated the 
interaction energy for the protein-protein and 
lipid-protein components of the interactions; this 
was achieved through scoring the interactions 
against the full set of functions contained in 
CCharPPI (28) (for the protein-protein 
component) and scoring using Prime MM-
GB/SA (for the lipid-protein component). Strike 
was then used to develop and evaluate binding 
affinity prediction models, using scores obtained 
from CCharPPI and Prime MM-GB/SA as 
descriptors for the model building. A model with 
high predictive performance was identified, and 
subsequently applied to predict the binding 
affinities of all Wnt-Fzd and Wnt-sFRP CRD 
interactions, in both mouse and human cases.  
 
RESULTS 
Preparation of homology models of Wnt-
Fzd CRD complexes–We prepared homology 
models of all mouse and human Wnts, and all 
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mouse and human Fzd and sFRP CRDs; details of 
UniProt accession numbers, sequence ranges and 
sequence alignments used to build the models are 
provided in the Supplemental Data (Table S1, 
Figures S2 and S3). The vast majority of proteins 
modelled did not feature large insertions or 
deletions relative to either XWnt8 or mFzd8 
CRD, with the exceptions of mouse and human 
Wnt6, Wnt10a and Wnt10b; these Wnts feature 
insertions relative to XWnt8 larger than that able 
to be built by Prime (greater than twenty 
residues). To build these structures, we utilized an 
alternative procedure incorporating the I-
TASSER server (described in detail in the 
Experimental Procedures), which is capable of 
building much longer insertions than Prime 
through its use of an iterative template fragment 
assembly approach to model building (29).  
Following assembly of the complexes 
and refinement using procedure automated using 
KNIME (Figure S4), the MolProbity score of all 
models was calculated. The MolProbity score 
provides a single value metric of structural 
quality, summarizing the number of atomic 
clashes, percentage of backbone conformations in 
regions outside the Ramachandran favored 
regions, and the percentage of bad side-chain 
rotamers (30). The TM-score and the root-mean-
squared deviation (RMSD) of the Cα atoms of the 
models with respect to the XWnt8-mFzd8 CRD 
complex structure (PDB 4F0A) (19), which was 
the template for all models, were also calculated. 
These measures assess differences in the co-
ordinates of two structures (31). The mean value 
for the MolProbity scores for the mouse and 
human models was slightly greater than the 
MolProbity score obtained for the XWnt8-mFzd8 
CRD complex structure (Table 1) but nonetheless 
comparable, indicating the generally high quality 
of the models. The mean values for the model 
TM-Scores with respect to the template crystal 
structure were generally high and the mean values 
for the model Cα RMSDs very low, further 
indicating the generally high quality of the 
models and their limited divergence from the 
template crystal structure. Selected complexes are 
shown in Figure 2. Quality metrics are 
summarized in Table 1, and full details are 
provided in the Supplemental Data (Tables S5-
S10). 
Development and validation of a Wnt-Fzd CRD 
binding affinity prediction model–We used a set 
of mouse Wnt-Fzd CRD binding affinities 
determined by BLI (27) to develop and validate 
our binding affinity prediction model. The model 
building and evaluation procedure is summarized 
in Figure 3, and herein described. 
Within the BLI data, we designated a 
training set, used to optimize the model, and a test 
set, used to demonstrate the performance of the 
model for data against which it had not been 
trained. Our training set was designated as 
complexes that were not part of our test set; our 
test set consisted of complexes involving 
interactions with either mFzd4 or mWnt1. The 
definition of the test set in this manner provided a 
simple means of selecting a test set covering a 
wide range of affinities. For all of these 
complexes, we then rescored, with separate 
procedures, the protein-protein portion and the 
lipid-protein portion of the interaction. The 
protein-protein portion was rescored against the 
majority of functions available within CCharPPI 
(28) (detailed in Table S11), a server compiling a 
wide range of scoring functions suitable for use in 
protein-protein docking. The lipid-protein portion 
was rescored used Prime MM-GB/SA, which 
provides a rapid means for evaluating ligand-
receptor binding energies with improved 
accuracy compared to typical docking scoring 
functions. The Prime MM-GB/SA calculation is 
also decomposed into its components 
(Coulomb/electrostatic, covalent binding, van der 
Waals, lipophilic, polar solvation/desolvation, 
hydrogen bonding and π-π components; 
components used in this study detailed in Table 
S11). The two strategies function 
complementarily to one another; the functions in 
CCharPPI are only capable of considering 
interactions between standard protein amino 
acids, while Prime MM-GB/SA is only capable of 
studying interactions between small organic 
molecules with proteins. With this in mind, the 
Wnt lipid was removed from the CCharPPI 
calculations, and the Wnt protein was removed 
from the Prime MM-GB/SA calculations (that is, 
only the interaction between the Wnt lipid and the 
Fzd CRD was assessed by Prime MM-GB/SA). 
Multiple linear regression models combining one 
Prime MM-GB/SA component with one or more 
CCharPPI components (all herein referred to as 
descriptors) were then generated, thus allowing 
the development of a single model considering 
both the protein-lipid and the protein-protein 
portions of the interaction. 
As it was computationally accessible to 
consider all possible three-descriptor models 
incorporating one Prime MM-GB/SA term and 
two CCharPPI-derived terms, we initially 
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explored these. The performance of all models 
was evaluated using two principle metrics:  
1) The root-mean-square error (RMSE) 
between the predicted values and the 
average experimental values 
(RMSEtrain, RMSEtest); lower values 
indicate a better fit between the 
predictions and experimental values 
2) The percentage of complexes for 
which the predicted value occurred 
within the experimental range 
reported (InExptrain, InExptest); higher 
values indicate a better fit between 
the predictions and experimental 
values 
High performing three-descriptor models 
of Wnt-Fzd CRD binding typically incorporated 
the van der Waals term of the Prime MM-GB/SA 
calculation (Table S12). The lipophilic term of 
the Prime MM-GB/SA calculation also appears 
frequently in high performing models. This is 
unsurprising considering the physicochemical 
properties of palmitoleic acid, which would 
suggest that the binding energy will likely be 
associated with van der Waals/non-polar 
interactions. The best performing three-descriptor 
models generally displayed root-mean-squared 
errors (RMSEs) for both the training and test sets 
in the range of 0.3-0.4 kcal/mol, well outside the 
error range of the experiments of approximately 
0.2-0.3 kcal/mol (27); this indicates that three-
descriptor models are insufficiently predictive. 
Two models containing four descriptors 
were identified that were capable of high 
prediction performance (Table 2). Both of these 
displayed RMSEs for the training and test sets 
less than 0.3 kcal/mol. Both included the van der 
Waals term of the Prime MM-GB/SA calculation, 
the PyRosetta hydrogen bonding potential 
(HBOND2) (32) and either the RW or RWplus 
statistical potentials (AP_calRW, AP_calRWp) 
(33). The fourth term in Model 1 is the antibody-
antigen energy function of FireDock 
(FIREDOCK_AB) (34), while in Model 2, it is 
the total RosettaDock weighted energy 
(ROSETTADOCK). As the performance of 
Model 1 appeared slightly improved over Model 
2, this model was selected for further study. 
Additionally, Model 1 was preferred over Model 
2 for featuring a smaller constant term, suggesting 
that it may be able to predict affinities over a 
wider range than Model 2. The RMSE values for 
Model 1 suggest that the error associated with its 
use will be slightly larger than, but nonetheless 
similar to, the error range achieved by 
experiment. 
The maximum difference between any 
prediction made by the model, either in the 
training set or the test set, is approximately 0.6 
kcal/mol, which corresponds to a difference in Kd 
of approximately one order of magnitude (Figure 
4, Table 3). Since there appears to be no particular 
Wnts or Fzds for which poor predictions are 
made, failure to make accurate predictions most 
likely occurs randomly and is not associated with 
a particular Wnt or Fzd structure; this is perhaps 
expected, given the overall high structural quality 
of the models used. The binding affinities of the 
vast majority of cases in the training and test sets 
are predicted within 0.25 kcal/mol of the mean 
experimental values reported, which is within the 
experimental error range. 
Further elaboration of the selected four-
descriptor models into five-descriptor models 
was performed, but did not result in models 
providing significant improvements in 
predictions (data not shown); similar RMSEs and 
a similar number of predictions occurring within 
the experimental ranges in both the training and 
test sets were obtained for the best four- and five-
descriptor models. Thus, four-descriptor models 
were deemed sufficient for use in predicting 
binding affinities. 
Prediction of binding affinities of Wnt-
CRD interactions–In applying Model 1 to predict 
Wnt-CRD binding affinities in the mouse 
proteins, numerous trends are apparent (Figure 
5A, Table S13). Fzd3, Fzd5, sFRP3 and sFRP4 
generally display high affinity, non-specific 
binding of Wnts, as evidenced by more than half 
of the interactions predicted to afford strong 
binding affinities (i.e., <10nM). Fzd8 also 
displays non-specific binding of Wnts; however, 
the majority of interactions are predicted to be of 
lower affinity than those with Fzd3, Fzd5, sFRP3 
and sFRP4. Fzd1, Fzd4, Fzd7 and Fzd9 generally 
display moderate affinity for a wide variety of 
Wnts. Fzd1, Fzd7 and Fzd9 display high affinity 
for limited Wnts, indicating more selective 
binding compared to Fzd3, Fzd5, Fzd8, sFRP3 
and sFRP4, while Fzd4 displays high affinity for 
several Wnts, indicating less selective binding. 
Fzd1 displays high affinity for Wnt6, Fzd7 
displays high affinity for Wnt10a, and Fzd9 
displays high affinity for both Wnt7a and Wnt16. 
Fzd2, Fzd6, Fzd10, sFRP1, sFRP2 and sFRP5 all 
display moderate to high affinity binding to less 
than half of the Wnts. However, this does not 
strictly translate to high selectivity; Fzd6 and 
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Fzd10 bind with moderate affinity to several 
Wnts. Fzd2 displays high affinity for Wnt3a, 
Wnt7b and Wnt10a. sFRP1, sFRP2 and sFRP5 all 
display high selectivity for specific Wnt ligands, 
however, retain moderate affinity for the majority 
of remaining Wnts. sFRP1 appears highly 
selective for Wnt7a, while sFRP2 is selective for 
Wnt2b and Wnt3a. sFRP5 displays moderate 
affinity for Wnt2b, Wnt5b and Wnt6. 
 The human data generally displays 
similar trends to the mouse data (Figure 5B, Table 
S14). Fzd3, Fzd5, sFRP3 and sFRP4 still display 
generally high affinity, non-specific binding of 
Wnts, however, there are some specific points of 
difference. The interactions of human Fzd3 with 
Wnt8a and Wnt9a are predicted to be much 
higher affinity than in the case of the mouse, 
although the hFzd9:hWnt9a interaction is still 
predicted to be of only moderate affinity. 
Conversely, the interaction of human Fzd3 with 
Wnt5b is predicted to be of much lower affinity 
than the equivalent mouse interaction. The 
affinity of the mouse Wnt2 for sFRP3 and sFRP4 
is predicted to be lower than the equivalent 
interactions in humans, however, Wnt9a is 
predicted to have increased affinity for these 
proteins in mouse compared to human. 
Significant differences in the predicted affinities 
of human Fzd4 for Wnt1, Wnt5a and Wnt11 
compared to the mouse interactions are observed, 
with all of these interactions predicted to be very 
low in binding affinity in humans, whereas in 
mice these are all predicted to be very high 
affinity. Large differences in the predicted 
affinities occur when comparing the interactions 
of mouse and human Fzd6, Fzd10, sFRP1, sFRP2 
and sFRP5 (Figure 5C); however, these 
interactions are generally predicted to be of low 
to moderate affinity and may not be indicative of 
different roles for Wnt interactions with these 
proteins in the two species. 
Analysis of residues of functional 
importance to Wnt-Fzd CRD interactions– 
To propose residues of functional importance to 
Wnt-Fzd interactions, all 570 Wnt-Fzd CRD 
models were subject to MM-GB/SA analysis with 
per-residue decomposition using AMBER14 
(35). This calculation allows the identification of 
specific residues making large contributions to 
the binding energy, which in turn, can be used to 
suggest the most significant intermolecular 
contacts in the interaction. High affinity 
complexes will generally have more residues 
making large contributions to the binding energy 
compared to low affinity complexes; thus, high 
affinity complexes will have greater influence on 
the designation of sequence positions of general 
importance to Wnt-Fzd CRD interactions. 
Analysis of Fzd CRD-binding regions of 
Wnt indicates two major regions utilized by Wnt 
in binding Fzd CRD (Figure 6A). These 
correspond to the thumb and index finger regions 
of Wnt, which are already well known as Fzd 
CRD-binding regions (19,36). Interestingly, Wnt 
residues beyond these two regions are rarely 
implicated in Fzd CRD binding (Figure S15) and 
the majority of Wnt residues in these regions 
frequently implicated in Fzd CRD binding are 
highly (often entirely) conserved in human and 
mouse Wnts. 
 In contrast to the Fzd CRD-binding 
regions of Wnt, which appear highly conserved 
and occupy relatively small sections of the Wnt 
sequence, the Wnt-binding regions of Fzd CRDs 
are distributed across several segments of the 
CRDs and often incorporate poorly conserved 
residues. Four sequences in the Fzd CRDs can be 
defined (Figure 6A), two of which interact with 
the Wnt thumb region and two of which interact 
with the Wnt index finger region; several 
additional residues of importance in specific 
cases (Figure S16). Highly conserved Fzd CRD 
residues frequently implicated in Wnt binding are 
generally associated with lipid binding: the FxP 
motif, which frequently occurs within a helix 
forming one side of the lipid-binding site of the 
Fzd CRD, and the phenylalanine of an FxW motif 
in the latter part of the sequence, both appear to 
interact with the Wnt palmitoleylation (Figure 
6B). Hydrophobic residues adjacent the final 
cysteine in the Fzd CRD are frequently implicated 
in binding the Wnt index finger, as are 
hydrophobic residues adjacent the fourth cysteine 
of the Fzd CRD. However, the involvement of 
particular Fzd CRD residues in binding is often 
highly influenced by sequence variation, even for 
positions frequently implicated in Wnt binding. 
The greatest deviations in the utilization of Wnt-
binding residues with respect to the set of Fzd 
CRDs occurs in Fzd3, Fzd6, sFRP3 and sFRP4. 
The region corresponding to the FxP motif in 
sFRP4 occurs as YEE; the tyrosine and glutamate 
residues in this sequence are never implicated as 
strong contributors to binding any Wnt. In sFRP3, 
the phenylalanine of the motif is retained, but the 
proline is replaced by glycine; the phenylalanine 
is strongly implicated in binding to all Wnts, 
while this is never the case for glycine. The 
glutamates of a motif frequently occurring as 
EAGLE are often implicated in Fzd CRD binding 
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to Wnt. In Fzd3 and Fzd6, the residue 
corresponding to the first glutamate is never 
strongly implicated in binding to any Wnt; this is 
replaced by a threonine in Fzd3 and an isoleucine 
in Fzd6. Substitution of this residue with aspartate 
(as occurs in several Fzds and sFRPs) or 
glutamine (as occurs in sFRP3 and sFRP4) does 
not appear to greatly influence the frequency with 
which this residue is involved in Wnt binding. 
Similarly, replacement of the second glutamate in 
the motif with alanine, as occurs in Fzd3, sFRP3 
and sFRP4 eliminates the importance of this 
position to Wnt binding, while retaining it as a 
glutamate (as in Fzd6 as other Fzds and sFRPs), 
aspartate or even glutamine does not seem to 
affect the frequency of its importance to binding. 
DISCUSSION 
In this study, we have developed a model 
for predicting binding affinity for Wnt-Fzd 
interactions. Although the model was developed 
against a relatively small set of data from a single 
study, there is nonetheless excellent agreement 
between affinities predicted in the current study 
and those experimentally determined in other 
studies which were not included in model 
building and testing here. The binding affinity of 
Wnt3a for the mouse sFRP3 was determined by 
surface plasmon resonance to be 7.9nM (37); our 
model predicts this interaction to be at 0.28nM, 
suggesting strong binding affinity. Binding 
affinities of Wnt3a, Wnt7a, Fzd10 and sFRP4 
measured using ELISA (38) confirm our model’s 
prediction that the Fzd5-Wnt3a interaction was 
stronger than that of Fzd10-Wnt7a and Wnt7a-
sFRP4. However, direct comparisons of Kd 
values predicted by our model and those 
determined by ELISA are challenging as our 
model has been optimized against BLI data, 
where a direct interaction is measured, whereas 
ELISA is a coupled assay; thus, Kd values 
obtained from BLI are likely to indicate higher 
affinity than those obtained from ELISA.  
 As experimentally determined binding 
affinities of Wnt-Fzd CRD interactions are 
largely limited to those included in our training 
and test sets, it is also pertinent to investigate 
whether interactions demonstrated 
experimentally through co-immunoprecipitation 
(coIP) were predicted by our model to have strong 
binding affinities. mFzd4-mWnt2b (39), hFzd4-
hWnt2 (40), mFzd4-mWnt7b (41), mFzd6-Wnt4 
(42) and hWnt3a-hSFRP4 (43), which were 
shown by coIP to interact, are predicted by our 
model to bind with an affinity in the intermediate 
or tighter range (<40nM). However, the 
interaction of sFRP1 with Wnt5a, which has been 
demonstrated by coIP (44), is suggested by our 
model to bind in the low micromolar range.  
While this would be within the range detectable 
by coIP, and is indeed a typical range for other 
interactions of biological relevance, particularly 
protein-carbohydrate interactions (45), binding 
affinities of functionally relevant Wnt-Fzd CRD 
interactions generally appear to occur in the low-
to-mid nanomolar range, as evidenced in the data 
upon which we have based our prediction model. 
Therefore, it is likely that the affinity of the 
sFRP1-Wnt5a interaction is drastically 
underestimated by the model.  
Despite the failure of the model in 
selected cases to achieve accurate predictions, the 
model nonetheless performs remarkably well at 
predicting binding affinities and likely 
interactors, particularly when considering that the 
Wnt-Fzd CRD interaction is rather complex due 
to involvement of both protein-protein and 
protein-lipid interactions at different sites. This 
would further suggest its usefulness in predicting 
the effect of Wnt/Fzd mutations to residues 
involved in either of the binding sites. The 
predictive success of the model is likely 
attributable to two main factors. The first is the 
use of a test set of cases separated from the 
training set in order to validate the model, which 
is not always performed in developing 
quantitative structure-activity relationships; even 
more remarkably, the use of an external data set 
for model validation appears to be a matter of 
some debate in the QSAR literature (46). The 
second is the incorporation of a term in the model 
specifically considering the contribution to 
binding made by the lipid. The direct involvement 
of Wnt lipidation in facilitating the Wnt-Fzd 
interaction is likely unusual among protein-
protein interactions; lipidation typically appears 
to influence only the solubility and localization of 
proteins, rather than directly facilitate protein-
protein interactions (47). However, other post-
translational modification of proteins, such as 
glycosylation, phosphorylation and methylation, 
are very common and are often involved in 
facilitating protein folding and mediating protein-
protein interactions (48-50). Since post-
translational modifications such as these are 
generally not accommodated in protein-protein 
docking and scoring, the strategy demonstrated 
here is one that could be adapted to facilitate their 
inclusion in protein-protein docking and scoring. 
This study has revealed trends with 
regards to the selectivity and promiscuity of Wnt 
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ligands for Fzd-CRDs. The study particularly 
highlights the promiscuous nature of sFRP4, a 
Wnt antagonist of interest to our group (51-56). 
SFRP3 is predicted to display similarly low 
selectivity for Wnt ligands, while SFRP1, SFRP2 
and SFRP5 are predicted to display much higher 
selectivity. The various levels of selectivity is 
likely to be due to the evolutionary development 
of tissue expression patterns of Wnt ligands and 
Fzd receptors, where sFRPs can partially limit 
aberrant Wnt signaling in order for controlled 
tissue development (57).  
This study has focused on the interactions 
of Wnt proteins with the Frizzled-type cysteine-
rich domains of the Fzd receptors and the secreted 
Frizzled-related proteins. However, a variety of 
other proteins also contain Frizzled-type CRDs, 
albeit less closely sequence-related to those of the 
Fzds and sFRPs. These include Smoothened, 
atrial natriuretic peptide-converting enzyme 
(CORIN), the tyrosine-protein kinase 
transmembrane receptors ROR1 and ROR2, the 
skeletal muscle receptor tyrosine-protein kinase 
(MuSK) (for which a structure of the Fzd CRD 
has been experimentally solved (58)), the 
collagen XVIII α-1 chain, carboxypeptidase Z 
and the membrane Frizzled-related protein. With 
the exception of the RORs (59-62), it is unknown 
if any Wnt binds to these proteins, and if so, if 
such an interaction is functionally relevant in the 
context of Wnt signaling. The approaches utilized 
in the current study could be applied to 
investigate the binding of Wnts to the Frizzled-
type CRDs of these proteins, which in turn, could 
stimulate further research into alternative Wnt 
signaling pathways. 
It is important to note that a high affinity 
interaction between a given Wnt and a given CRD 
does not necessarily translate into a signal 
transduction event. Wnt signaling involves 
several additional proteins both extracellularly 
and intracellularly. For example, in canonical 
Wnt signaling, Wnt binds to a Fzd CRD, as well 
as the co-receptor LRP5/6 (63); on the 
intracellular side, this likely causes a 
conformational change in Fzd, resulting in 
movement of the Fzd intracellular loop 3 and C-
terminal helix, which in turn, permits Dvl binding 
and subsequent signal transduction (64,65). Thus, 
the biological relevance of given Wnt-Fzd CRD 
interactions will be influenced by the co-
expression/co-localization of these other proteins. 
Recent structural data on LRP6 (66-68) and the 
Smoothened receptor, a Class F GPCR related to 
Fzd receptors (69-72), as well as the availability 
of Dvl domain structures (73-76) and knowledge 
of key residues in the Fzd-Dvl interaction 
(64,77,78) provide the opportunity to investigate 
more completely the structural basis of canonical 
Wnt signaling. Additionally, the structures of 
several intracellular components in non-canonical 
Wnt signaling pathways are known or adopt 
structurally characterized folds, suggesting the 
potential for structural investigations. The models 
generated in this study provide a solid basis by 
which to pursue further structural studies of Wnt 
signaling, and perhaps of greater importance 
given the combinatorial nature of potential Wnt-
Fzd interactions, suggest specific interacting 




Template preparation–The template 
structure for all models was the complex of the 
Xenopus Wnt8 (XWnt8) with the mouse Fzd8 
CRD (PDB 4F0A) (19). This structure was 
initially processed by the Protein Preparation 
Wizard, with missing side chain and loops filled 
in by Prime. Although the identity of the lipid 
modification to XWnt8 in this structure could not 
be conclusively determined (19), we have 
presumed this modification to be palmitoleic 
acid, as indicated either by direct experimental 
evidence or comparison to similar sequences for 
which this modification has been demonstrated 
(18,79-83). The lipid in the structure was 
manually modified using Maestro to be a 
palmitoleic acid modification, which involved the 
creation of a double bond between carbons 9 and 
10, and the addition of carbons 15 and 16 to the 
lipid, which were missing from the structure. The 
lipid was subject to a Monte Carlo multiple 
minimum (MCMM) conformational search using 
Macromodel, with the region comprising carbons 
9-16, as well as the hydrogen atoms attached to 
these carbons, defined as a freely-moving 
substructure, residues within 6.0 Å of this defined 
as a frozen shell, and a torsional constraint to 
ensure cis double bond geometry about carbons 9 
and 10. Automatic setup of the substructure was 
employed to define rotatable bonds to be 
searched, however, all torsion check parameters 
were removed. Extended torsion sampling was 
employed. A maximum number of 10000 steps 
for the search was employed, with a maximum of 
2000 steps per rotatable bond. The lowest energy 
structure obtained from the search provided a 
template structure for the lipid, used in all models. 
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Homology modelling–Sequences of 
Wnts, Frizzled and sFRP CRDs from both mouse 
and human were obtained from the UniProt 
database (84) (accession numbers provided in 
Supplemental Data, Table S1). Homology models 
were prepared using Prime 4.1 (85) (sequence 
ranges and alignments used provided in 
Supplemental Data, Figures S2 and S3). All 
models were prepared using knowledge-based 
building, however, due to the presence of large 
insertions in the human and mouse Wnt6, Wnt10a 
and Wnt10b sequences relative to XWnt8, an 
alternative strategy to building these structures 
was performed (vide infra). Disulfide bonds c13-
c17 and c16-c24 in Wnt (see (36) for description 
of cysteine numbering in Wnts) typically could 
not be created during the model building process 
due to being adjacent to insertions/gaps in the 
sequence alignment; these bonds were manually 
inserted and the residues involved energy 
minimized. The lipid structure generated during 
template preparation was not included during 
Wnt model building, but manually attached 
following model building. 
To build the structures of the human and 
mouse Wnt6, Wnt10a and Wnt10b, an initial 
model of the complete mouse Wnt10a was 
generated using the I-TASSER server (86). 
Structures of the remaining Wnts were then built 
using knowledge-based building in Prime against 
both the mouse Wnt10a model generated by I-
TASSER (to provide the structure of the 
insertion) and the XWnt8 structure (to provide a 
template for modelling the remainder of the 
structure). 
Complex generation and refinement–All 
combinations of Wnt-CRD complexes were 
generated by merging the structures of each of the 
models built in the previous step. The generated 
complexes were subject to refinement using 
Prime 4.1. The refinement process was facilitated 
through the use of a KNIME workflow (Figure 
S4). In each complex, non-template residues and 
residues within 6.0 Å of the binding interface 
were subject to Prime Minimization, Prime Side-
chain Prediction, followed by a second Prime 
Minimization. The Wnt lipidation was excluded 
from the first minimization, to allow CRD 
residues to relax around it, but included in the 
second minimization. For complexes involving 
mouse and human Wnt6, Wnt10a and Wnt10b, 
the large insertions modelled by I-TASSER were 
also subject to the refinement procedure. The 
quality of the refined models was assessed using 
the MolProbity score, as calculated by the 
MolProbity module within PHENIX (87). The 
quality of the refined models was also assessed by 
calculating the root-mean-squared deviation 
(RMSD) of the Cα atoms and the TM-Score with 
respect to the XWnt8-mFzd8 CRD complex. 
These measurements were both calculated using 
MM-align (88), with the option to enforce 
interface alignment by the default cutoff enabled. 
Development and validation of the 
binding affinity prediction model–Complexes of 
mouse Wnt3a, Wnt4, Wnt5a and Wnt5b with 
mouse Fzd1, Fzd2, Fzd4, Fzd5, Fzd7 and Fzd8 
were rescored using all of the scoring functions 
contained in the CCharPPI server (28). As the 
scoring functions are generally only capable of 
considering interactions between protein 
residues, the lipid modification to Wnt was 
removed prior to rescoring. In order to consider 
contributions to the binding affinity made by the 
lipid, Prime MM-GB/SA calculations on the 
interaction between the lipid and the CRDs were 
performed. For these calculations, the protein 
component of Wnt was removed. 
 The scores for each complex by each 
scoring function in CCharPPI, as well as the 
values of the terms provided by the Prime MM-
GB/SA calculations, were loaded into Maestro. A 
property containing the dissociation constants 
determined by BLI for selected mouse Wnt-Fzd 
CRD pairs (27) was manually created and used to 
define the activity property. Complexes involving 
interactions with either Wnt4 or Fzd1 comprised 
the test set, while all other complexes comprised 
the training set; the training and test sets are 
summarized in the Results section (Table 3). Both 
the training and test sets cover a diverse range of 
Wnts, Fzds and binding affinities for Wnt-Fzd 
interactions. 
Strike was used to generate affinity 
prediction models. Multiple linear regression was 
used to build models. Functions from CCharPPI 
and properties from Prime MM-GB/SA provided 
the descriptors used in model building; the full list 
of functions and properties considered in model 
building is provided in Table S5 of the 
Supplemental Data. The success of the models in 
predicting binding affinities for complexes in 
both the training and test sets was evaluated using 
RMSE and the percentage of complexes for 
which the predicted value occurred within the 
experimental range (RMSEtrain, RMSEtest, 
InExptrain, InExptest). 
All possible three-descriptor models 
incorporating one term from Prime MM-GB/SA 
and the remaining two terms from CCharPPI were 
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investigated. Models with RMSEtrain less than 0.5 
kcal/mol and InExptrain greater than 50% were 
selected for testing. Models performing at least as 
well for the test set for the training set (i.e., 
RMSEtest ≤ 0.5 kcal/mol and InExptest ≥ 50%) 
were selected for further elaboration into four-
descriptor models, which were generated by 
adding an additional term from CCharPPI to the 
best performing three-descriptor models. Four-
descriptor models giving RMSEtrain and RMSEtest 
less than 0.3 kcal/mol and InExptrain and InExptest 
greater than 75% were selected as high 
performing models. Elaboration of the four-
descriptor models into five-descriptor models 
was also pursued, by adding another term from 
CCharPPI. 
As a final check of model quality, we 
have also checked if the approximate range of 
binding affinity predicted by the best models is in 
that expected. Dijksterhuis et al. (27) used a 
simplified scheme wherein Wnt-Fzd binding 
affinities were classified as strong (<10nM, 
++++), intermediate (10-40nM, +++), weak (40-
100nM, ++), very weak (>100nM, +), and non-
binding (-). We have utilized this scheme with 
some modification; we have considered 
predictions of 100-400nM to constitute the very 
weak (+) category, and predictions greater than 
400nM to be effectively non-binding (-); the 
400nM limit was chosen in relation to the 
intermediate/weak affinity range defined. 
Analysis of functional residues in Wnt-
Fzd interactions–All 570 Wnt-Fzd CRD models 
were subject to MM-GB/SA analysis using 
AMBER14 (35). Wnt-Fzd complexes were 
parameterized using the ff14SB force field (89). 
Parameter generation for O-palmitoleylserine 
was facilitated by antechamber (90), adapting 
procedures described in both the AMBER14 
Reference Manual and AMBER tutorials. 
MMPBSA.py facilitated MM-GB/SA 
calculations (91). The modified generalized Born 
model of Onufriev, Bashford and Case (igb=5) 
(92) with a salt concentration of 0.1 M was used 
to calculate the polar desolvation energy. The 
non-polar desolvation energy was calculated 
using surface areas derived from the LCPO 
method (93) multiplied by surface tension (the 
default of 0.0072 kcal/(mol Å2) was used). 
Energies calculated by MM-GB/SA were 
decomposed on a per-residue basis, with 1-4 
terms added to the internal potential terms 
(idecomp=1) (94). Residues contributing greater 
than ±2.0 kcal/mol to the total MM-GB/SA 
binding energy were selected as being of 
functional importance to binding. Logo analysis 
of regions within the Wnt and Fzd sequences 
frequently found to contain residues of functional 
importance to Wnt-Fzd binding was performed 
using the WebLogo server (95). Sequence logos 
were generated as frequency plots.
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Table 1. Summary of model quality metrics. 
 
 XWnt8:mFzd8 CRD complex Mouse modelsb Human modelsb 
MolProbity Score 1.72 2.13 ± 0.46 2.08 ± 0.42 
TM-Scorea 1.00 0.91 ± 0.04 0.91 ± 0.05 
Cα RMSDa 0.00 Å 1.39 ± 0.39 Å 1.39 ± 0.45 Å 
aTM-Score and Cα RMSDs calculated with respect to the XWnt8:mFzd8 CRD complex (PDB 4F0A). 
By definition, the TM-Score for an optimally overlaid structure compared to itself is one; the RMSD 
for an optimally overlaid structure compared to itself is zero. bMean values ± two standard deviations 
shown; data for individual complexes shown in Supplemental Data (Tables S5-S10). 
 
Table 2. Best performing four-descriptor models predicting Wnt-Fzd CRD binding energy. 
 





1 ΔG = 0.0038165 × AP_calRW – 
0.22506 × MMGBSA dG Bind 
vdW – 0.24626 × HBOND2 – 
0.049875 × FIREDOCK_AB – 
3.3475 
0.23 0.27 80% 75% 
2 ΔG = 0.0021829 × AP_calRWp – 
0.22111 × MMGBSA dG Bind 
vdW – 0.20861 × HBOND2 – 
0.08699 × ROSETTADOCK – 
7.7974 
0.30 0.23 73% 75% 
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-10.64 -11.16 0.52 15.7 6.5 +++ (++++) Training 
mWnt3a-
mFzd4 
-11.27 -11.21 0.06 5.4 6.0 ++++ (++++) Training 
mWnt3a-
mFzd5 
-11.60 -11.65 0.05 3.1 2.9 ++++ (++++) Training 
mWnt3a-
mFzd7 
-11.28 -10.85 0.43 5.3 11.0 ++++ (+++) Training 
mWnt3a-
mFzd8 
-12.03 -11.86 0.17 1.5 2.0 ++++ (++++) Training 
mWnt5-
mFzd2 
-10.38 -10.33 0.05 24.4 26.5 +++ (+++) Training 
mWnt5-
mFzd4 
-10.38 -10.26 0.12 24.4 29.9 +++ (+++) Training 
mWnt5-
mFzd5 
-11.31 -11.19 0.12 5.1 6.2 ++++ (++++) Training 
mWnt5-
mFzd7 
-10.05 -9.98 0.07 42.6 47.9 ++ (++) Training 
mWnt5-
mFzd8 
-11.45 -11.43 0.02 4.0 4.1 ++++ (++++) Training 
mWnt5b-
mFzd2 
-9.60 -9.47 0.13 91.0 113.4 ++ (+) Training 
mWnt5b-
mFzd4 
-9.95 -10.29 0.34 50.4 28.4 ++ (+++) Training 
mWnt5b-
mFzd5 
-10.44 -10.35 0.09 22.0 25.7 +++ (+++) Training 
mWnt5b-
mFzd7 
-9.65 -9.89 0.24 83.7 55.8 ++ (++) Training 
mWnt5b-
mFzd8 
-11.04 -11.19 0.15 8.0 6.2 ++++ (++++) Training 
mWnt3a-
mFzd1 
-10.66 -10.61 0.05 15.2 16.5 ++++ (++++) Test 
mWnt4-
mFzd2 
-9.53 -9.53 0.00 102.5 102.5 + (+) Test 
mWnt4-
mFzd4 
-10.04 -9.72 0.32 43.3 74.3 ++ (++) Test 
mWnt4-
mFzd5 
-10.68 -11.25 0.57 14.7 5.6 +++ (++++) Test 
mWnt4-
mFzd7 
-9.58 -9.83 0.25 94.2 61.7 + (+) Test 
mWnt4-
mFzd8 
-10.95 -10.70 0.25 9.3 14.2 ++++ (+++) Test 
mWnt5-
mFzd1 
-10.33 -10.31 0.02 26.5 27.4 +++ (+++) Test 
mWnt5b-
mFzd1 
-9.60 -9.85 0.25 91.0 59.7 + (+) Test 
aKd values were obtained from Dijksterhuis et al. (27) and represent the average values reported. All Kd 
values expressed in nM. bΔGexp calculated from experimental Kd values as ΔG = RT ln Kd, where R is 
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the gas constant (1.987 × 10-3 kcal K-1 mol-1) and T is the temperature at standard conditions (298K). 
Predicted ΔG (ΔGpred) calculated according to Model 1. ΔG values expressed as kcal/mol. cAbsolute 
value of difference between experimental and predicted ΔG values. dGuide to affinity range 
classifications: <10nM – ++++; 10-40nM – +++; 40-100nM – ++; 100-400nM – +; >400nM – -. Cases 
in which the experimental and predicted Kd values occur in different ranges are underlined. Range in 
which value of experimental Kd occurs shown outside parentheses; range in which predicted Kd value 
occurs shown inside parentheses. 
 
  




FIGURE 1. Wnt signaling pathways. A. Canonical Wnt signaling. Wnt binding to Fzd-CRD initiates 
the destabilisation of the cytoplasmic destruction complex (APC, Axin, GSK3, CK1, Dvl). This 
allows cytosolic β-catenin accumulation and subsequent translocation to the nucleus where it binds to 
TCF/LEF transcription factors to transcribe Wnt target genes. SFRPs antagonise this cascade and β-
catenin is polyubiquitinated by β-TrCP and degraded by proteolysis. B. The Wnt/Ca2+ pathway. Wnt 
binding to Fzd-CRD, or Ryk co-receptor activates Dvl, which stimulates calcium release. 
Downstream effectors PKC, CaMKII and Calcineurin (Cn) activate transcription factors CREB, NF-
κB and NFAT. C. The planar cell polarity (PCP) pathway. Wnt stimulation is effected initially 
through Fzd-Dvl interaction and co-receptors ROR/Ryk and passed through multiple effectors 
downstream to ROCK and JNK. ROCK regulates the actin cytoskeleton and JNK activates AP1 and 
JUN transcription factors to regulate cell polarity and migration. 
 
FIGURE 2. Homology models of selected Wnt-Fzd CRD complexes overlaid to the repaired 
XWnt8:mFzd8 CRD crystal structure (PDB 4F0A). Figure legend: grey – repaired PDB 4F0A; pink – 
mWnt5:mFzd1 CRD complex; yellow – mWnt10a:mFzd6 complex; green – hWnt3a:hSFRP4 CRD 
complex; cyan – hWnt2b:hFzd9 CRD complex. Lipid shown in all structure as sticks with transparent 
spheres. 
 
FIGURE 3. Overview of the model building process. RMSE and InExp cutoffs used to select models 
at the relevant stages of model building are described in the Experimental Procedures. 
 
FIGURE 4. Comparison of binding energy predictions by Model 1 in the training set (A) and test set 
(B). Points indicated by open squares are those where the predicted binding energy falls outside the 
model RMSE (0.23 kcal/mol for the training set; 0.27 kcal/mol for the test set). 
 
FIGURE 5. Binding affinity predictions by Model 1 for Wnt-Fzd interactions. A. Mouse interactions. 
B. Human interactions. C. Binding affinity differences (ΔKd) between equivalent Wnt-Fzd 
interactions of mouse and human, calculated as ΔKd = mouse Kd – human Kd. Positive ΔKd is 
indicative of a lower affinity interaction in mouse compared to human; negative ΔKd indicates a 
higher affinity interaction in mouse compared to human. 
 
FIGURE 6. Residues making significant contributions to the binding energy in the majority of Wnt-
Fzd CRD complexes. A. Logo analyses of Wnts (first row) and Fzd CRDs (second two rows), 
highlighting the major regions involved in interactions. Fzd sequences interacting with a specific 
region of Wnt are shown below the sequence of Wnt corresponding to that region. Color guide to 
logos: green – aromatic residues (Trp, Phe, His, Tyr); grey – aliphatic residues (Val, Leu, Ile, Met, 
Ala); blue – basic residues (Arg, Lys); red – acidic residues (Asp, Glu); yellow – cysteine; light blue – 
palmitoleyl serine (panel A only); black – all other residues (Gly, Pro, Ser, Thr, Gln, Asn). Logos 
presented as frequency plots. Intensity of purple shading indicates the number of complexes in which 
the residue at that position is a significant contributor to the complex binding energy. B, C. Cross-
eyed stereo views of the “front” (B) and rear (C) of the XWnt8-mFzd8 crystal structure complex 
(PDB 4F0A), with major interacting regions highlighted. Residues corresponding to positions 
frequently involved in interactions across the full set of Wnt-Fzd CRD complexes are shown as sticks. 
Regions are colored according to the caption color in Figure 5A. The “front” view displays the 
regions of the middle row of Figure 5A; the “rear” view displays the regions of the bottom row of 
Figure 5A. 
  























Wnt-Fzd CRD binding affinity prediction 
 
FIGURE 6 
 
